From: S100A14 protein as diagnostic and prognostic marker in hepatocellular carcinoma
Cirrhosis group | HCC group | Control group | One-way ANOVA | |||||
---|---|---|---|---|---|---|---|---|
Mean ± SD | Min─max | Mean ± SD | Min─max | Mean ± SD | Min─max | F | p value | |
S.GPT (U/L) | 55.91 ± 33.84 | 15–138 | 66.71 ± 43.17 | 22–201 | 15.35 ± 5.37 | 10–26 | 14.763 | 0.001 |
S.GOT (U/L) | 84.71 ± 49.10 | 20–244 | 145.77 ± 161.89 | 30–821 | 18.85 ± 6.54 | 12–34 | 9.371 | 0.001 |
Albumin (g/dl) | 2.40 ± 0.61 | 1.4–3.8 | 2.24 ± 0.55 | 1.3–3.6 | 4.34 ± 0.31 | 3.8–4.8 | 112.256 | 0.001 |
Bilirubin Total (mg/dl) | 4.25 ± 3.89 | 0.46–20.7 | 5.92 ± 6.51 | 0.6–21.5 | 0.44 ± 0.17 | 0.2–0.8 | 8.561 | 0.001 |
Bilirubin Direct (mg/dl) | 2.14 ± 2.09 | 0.1–10.7 | 3.35 ± 4.04 | 0.2–12.8 | 0.15 ± 0.05 | 0.1–0.2 | 8.080 | 0.001 |
Hemoglobin (g/dl) | 10.23 ± 1.99 | 6–14.8 | 10.97 ± 1.42 | 8.3–14.6 | 12.14 ± 1.58 | 9.6–14.8 | 8.046 | 0.001 |
RBCs (× 106/μL) | 3.59 ± 0.79 | 2.22–5.57 | 3.86 ± 0.58 | 3.2–5.79 | 4.45 ± 0.43 | 3.71–5.55 | 11.384 | 0.001 |
PLT (× 103/μL) | 111.71 ± 71.43 | 24–342 | 114.31 ± 67.52 | 18–288 | 267.75 ± 52.54 | 174–356 | 42.545 | 0.001 |
WBC (× 103/μL) | 7.99 ± 3.41 | 3–15 | 8.89 ± 5.14 | 2.5–18.3 | 6.62 ± 1.29 | 4.2–9 | 2.163 | 0.121 |